Orphan receptor NR4A3 is a novel target of p53 that contributes to apoptosis

O Fedorova, A Petukhov, A Daks, O Shuvalov… - Oncogene, 2019 - nature.com
O Fedorova, A Petukhov, A Daks, O Shuvalov, T Leonova, E Vasileva, N Aksenov, G Melino
Oncogene, 2019nature.com
Major tumor suppressor and transcription factor p53 coordinates expression of many genes
hence affecting critical cellular functions including cell cycle, senescence, and apoptosis.
The NR4A family of orphan receptors (NR4A1-3) belongs to the superfamily of nuclear
receptors. They regulate genes involved in proliferation, cell migration, and apoptosis. In this
study, we report an identification of NR4A3 as a direct transcriptional target of p53. Using
various techniques, we showed that p53 directly bound the promoter of NR4A3 gene and …
Abstract
Major tumor suppressor and transcription factor p53 coordinates expression of many genes hence affecting critical cellular functions including cell cycle, senescence, and apoptosis. The NR4A family of orphan receptors (NR4A1-3) belongs to the superfamily of nuclear receptors. They regulate genes involved in proliferation, cell migration, and apoptosis. In this study, we report an identification of NR4A3 as a direct transcriptional target of p53. Using various techniques, we showed that p53 directly bound the promoter of NR4A3 gene and induced its transcription. Functionally, over-expression of NR4A3 attenuated proliferation of cancer cells and promoted apoptosis by augmenting the expression of pro-apoptotic genes, PUMA and Bax. Knockdown of NR4A3 reversed these phenotypes. Importantly, NR4A3 exhibited tumor suppressive functions both in p53-dependent and independent manner. In addition, NR4A3 physically interacted with an anti-apoptotic Bcl-2 protein hence sequestering it from blunting apoptosis. These observations were corroborated by the bioinformatics analysis, which demonstrated a correlation between high levels of NR4A3 expression and better survival of breast and lung cancer patients. Collectively, our studies revealed a novel transcriptional target of p53, NR4A3, which triggers apoptosis and thus likely has a tumor suppressive role in breast and lung cancers.
nature.com